(LEXX) – FDA
-
Lexaria Bioscience (LEXX) Receives Approval to Begin New GLP-1 Study
-
Lexaria Bioscience (LEXX) Announces FDA Clearance for Planned US Phase 1b Hypertension Trial
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LEXX Stock Lookup